Increased risk of atherothrombotic events associated with cytochrome P450 3A5 polymorphism in patients taking clopidogrel

BACKGROUND: Clopidogrel is a prodrug requiring metabolism by cytochrome P450 3A (CYP3A) isoenzymes, including CYP3A5, in order to be active. It is controversial whether clopidogrel interacts with CYP3A inhibitors. We investigated the influence of CYP3A5 polymorphism on the drug interaction of clopid...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Suh, Jung-Won, Koo, Bon-Kwon, Zhang, Shu-Ying, Park, Kyung-Woo, Cho, Joo-Youn, Jang, In-Jin, Lee, Dong-Soon, Sohn, Dae-Won, Lee, Myoung-Mook, Kim, Hyo-Soo
Формат: Artigo
Язык:Inglês
Опубликовано: Canadian Medical Association 2006
Предметы:
Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC1471813/
https://ncbi.nlm.nih.gov/pubmed/16754899
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1503/cmaj.060664
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы